Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance Study of [14C]SSS17 in Healthy Chinese Males
NCT07025915Phase 1Not yet recruiting
- Sponsor
- 3SBio
- Start
- Jun 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of SSS-17 in anemia, sponsored by 3SBio. Primary endpoints: Cumulative excretion rate of radioactivity in excreta (urine, feces) and total radioactivity (urine and feces), Maximum Plasma Concentration (Cmax) and 1 more. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
SSS-17
03
Conditions
anemia
Beyond the preview
Go deeper on NCT07025915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07025915.